Merck (MRK) Treasury Shares (2009 - 2026)

Merck has disclosed Treasury Shares across 18 years of filings, most recently posting $63.7 billion for Q1 2026.

• In Q1 2026, Treasury Shares rose 7.32% year-over-year to $63.7 billion; the TTM figure through Mar 2026 stood at $63.7 billion (up 7.32% YoY), while the FY2025 annual figure was $63.0 billion, up 8.05% from the prior year.
• Treasury Shares advanced to $63.7 billion in Q1 2026, from $63.0 billion in the prior quarter.
• Over the last five years, Treasury Shares for MRK reached as high as $1.1 billion in Q1 2026 and fell as low as $4.0 million in Q3 2023.
• The 5-year median for Treasury Shares is $1.0 billion (2022), against an average of $872.4 million.
• Annual changes were most pronounced in 2022 — Treasury Shares slipped 1.09% — and 2025, when it grew 8.05%.
• A 5-year view of Treasury Shares shows it stood at $56.5 billion in 2022, then gained by 1.7% to $57.4 billion in 2023, then gained by 1.48% to $58.3 billion in 2024, then grew by 8.05% to $63.0 billion in 2025, then gained by 1.19% to $63.7 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $63.7 billion, $63.0 billion, and $61.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.